ENZON HEADER PIC
Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.'s financial performance into perspective.

 

 

 

Stock Information
(ENZN) NASD
Last Trade 9.480
Change(%) + 0.16
Volume 515,900
May 9, 2008 3:10 PM ET
New Product Release
Lab Look
Our four proprietary marketed brands are ABELCET®, ADAGEN®, DEPOCYT®, and ONCASPAR®. To learn more about our recent product releases CLICK HERE
Shareholder Tools